Abstract
To understand the characteristics of prescriptions and costs in pediatric patients with acute upper respiratory infections (AURI) is important for the regulation of outpatient care and reimbursement policy. This study aims to provide evidence on these issues that was in short supply. We conducted a retrospective cross-sectional study based on data from National Engineering Laboratory of Application Technology in Medical Big Data. All outpatient pediatric patients aged 0-14 years with an uncomplicated AURI from 1 January 2015 to 31 December 2017 in 138 hospitals across the country were included. We reported characteristics of patients, the average number of medications prescribed per encounter, the categories of medication used and their percentages, the cost per visit and prescription costs of drugs. For these measurements, discrepancies among diverse groups of age, regions, insurance types, and AURI categories were compared. Kruskal-Wallis nonparametric test and Student-Newman-Keuls test were performed to identify differences among subgroups. A multinomial logistic regression was conducted to examine the independent effects of those factors on the prescribing behavior. A total of 1,002,687 clinical records with 2,682,118 presc...Continue Reading
References
Jun 1, 1997·The Pediatric Infectious Disease Journal·L HuiH M Foy
Mar 27, 1998·JAMA : the Journal of the American Medical Association·A C NyquistM A Sande
Mar 20, 2003·Pharmacoepidemiology and Drug Safety·Christoph SchindlerWilhelm Kirch
Jul 27, 2006·Fundamental & Clinical Pharmacology·Biswadeep DasAbhijeet Guha Majumder
Apr 11, 2008·The Journal of Antimicrobial Chemotherapy·Lifang DongDuolao Wang
Jun 25, 2009·Health Economics·Wanchuan LinGang Chen
Jul 8, 2010·Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine·Anuja A PandeyPrakash R Bhatkule
Jun 27, 2013·The Journal of Antimicrobial Chemotherapy·Xiaoxv YinZuxun Lu
Feb 18, 2014·Family Practice·Xiaoyun LiangChenggang Jin
Oct 7, 2014·JAMA Internal Medicine·Jin WangYonghong Xiao
Mar 15, 2015·PloS One·Lidao BaoHaijun Lyu
Mar 21, 2015·PloS One·Wenhui MaoShenglan Tang
May 2, 2015·Journal of Korean Medical Science·Sun Mi ShinByung-Joo Park
Oct 9, 2015·Infectious Diseases of Poverty·Juan YangHong-Jie Yu
Dec 27, 2015·European Journal of Clinical Pharmacology·Yiqun WuYonghua Hu
May 4, 2016·JAMA : the Journal of the American Medical Association·Katherine E Fleming-DutraLauri A Hicks
May 14, 2016·Medicine·Jing LiZuxun Lu
Jan 28, 2017·International Journal of Antimicrobial Agents·Yuan-Yuan WangYuan-Ying Jiang
Apr 30, 2017·Journal of Public Health·Satomi YoshidaKoji Kawakami
May 4, 2017·Global Health Action·Zhitong ZhangXiaolin Wei
Aug 22, 2017·Social Science & Medicine·Anwen ZhangElias Mossialos
Dec 2, 2017·BMC Medical Informatics and Decision Making·Wei-Hung WengHenry C Chueh
Dec 13, 2017·Lancet·Xi LiShengshou Hu
Dec 14, 2017·Scientific Reports·Xu-Xiang LiuXi-Ling Wang
Aug 15, 2018·BMC Health Services Research·Hao-Miao LiXiao-Mei Hu
Nov 9, 2018·The Pediatric Infectious Disease Journal·Abiy AgiroAlan Rosenberg
Sep 1, 2017·International Journal of Pediatrics & Adolescent Medicine·Helena C MaltezouMaria Theodoridou